StockData
Avalyn Pharma Inc. logo

Avalyn Pharma Inc. (AVLN) stock

AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.70+1.01 (+3.65%)

Close on Nov 19, 2026Market cap $1.27BP/E –Yield –

Avalyn Pharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$26.35M–
Q1 FY2026Mar 31, 2026-$30.21M–
Q2 FY2025Jun 30, 2025-$20.70M–
Q1 FY2025Mar 31, 2025-$19.28M–

More Avalyn Pharma figures

See a number that looks wrong?